Should You Treat This Patient for UTI?
Yes, treat this patient for UTI, but the decision depends critically on whether the patient has symptoms and specific risk factors—the presence of both E. coli and S. aureus in urine demands careful clinical assessment rather than reflexive treatment.
Clinical Decision Framework
Step 1: Determine if Symptoms Are Present
If the patient has UTI symptoms (dysuria, frequency, urgency, fever, flank pain, suprapubic tenderness):
- Treat immediately 1
- E. coli is the most common cause of uncomplicated cystitis and is almost certainly pathogenic 1
- S. aureus co-isolation raises concern for complicated UTI or hematogenous seeding
If the patient is asymptomatic:
- Do NOT treat in most cases 2
- This represents asymptomatic bacteriuria (ASB), which should not be treated except in specific high-risk scenarios
Step 2: Assess for High-Risk Features
The presence of S. aureus alongside E. coli is unusual and warrants heightened concern. S. aureus bacteriuria occurs in only 0.2-4% of positive urine cultures and often signals:
Critical risk factors requiring treatment even if asymptomatic:
- Upcoming urologic procedure with mucosal trauma (strong indication to treat) 2
- Indwelling urinary catheter with planned instrumentation 3
- Recent or concurrent bacteremia risk (recent IV catheter, phlebitis, hospitalization) 4, 5
High-risk features suggesting complicated UTI:
- Urinary catheterization (present in 82% of S. aureus bacteriuria cases) 4
- Hydronephrosis (7-fold increased risk of symptomatic S. aureus UTI) 3
- Renal stones 3
- Male sex, diabetes, urologic abnormalities 1, 6
Step 3: Consider S. aureus Bacteremia Risk
Obtain blood cultures if:
- Patient has fever, hemodynamic instability, or systemic signs 7
- Recent urologic instrumentation 6
- Recent hospitalization or IV catheter exposure 5
Key evidence: 48.8% of S. aureus bacteriuria cases have concurrent bacteremia 7, and 13% are bacteremic at initial isolation 4. Mortality reaches 47.6% in bacteremic cases 7. However, in patients WITHOUT prior urinary tract intervention, the likelihood of hematogenous seeding (bacteremia causing bacteriuria) increases to 81% 7.
Step 4: Treatment Approach
For symptomatic or high-risk patients requiring treatment:
Empiric therapy (pending susceptibility results):
- Follow complicated UTI guidelines given polymicrobial nature 1
- Consider: Amoxicillin + aminoglycoside OR 2nd/3rd generation cephalosporin + aminoglycoside 1
- Duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 1
Tailor therapy based on culture sensitivities:
- E. coli: First-line agents per local resistance patterns 1
- S. aureus: 86% are MRSA in long-term care settings 4; adjust based on susceptibility
For asymptomatic low-risk patients:
- Do not treat 2
- Consider repeat urine culture if risk factors present (catheterization, urologic abnormality, diabetes) 6
Critical Pitfalls to Avoid
Do not treat asymptomatic bacteriuria reflexively just because cultures are positive—this increases C. difficile risk, antimicrobial resistance, and adverse drug effects without benefit 2
Do not assume contamination when S. aureus appears with E. coli—this combination suggests either complicated UTI or hematogenous seeding requiring investigation 4, 5, 7
Do not miss occult bacteremia—S. aureus bacteriuria can be the first sign of staphylococcal bacteremia, particularly in hospitalized patients with IV access 5, 7
Do not use short-course therapy for complicated UTI—the presence of both organisms indicates complicated infection requiring 7-14 days of treatment 1